bioRxivBioinformaticsPreprint
Systematic Evaluation of Transfer Learning Strategies for Clinical Chemotherapy Response Prediction
Abstract
Accurately predicting chemotherapy response remains a major challenge in precision oncology. Although machine-learning models based on tumour omics data have shown promise, the majority of existing studies are trained and evaluated on pre-clinical cell-line datasets, leaving their clinical applicability insufficiently characterised. In this study, we systematically evaluate a range of transfer-learning strategies for chemotherapy response prediction under realistic clinical constraints using patient data from The Cancer Genome Atlas (TCGA). Rather than proposing a new predictive model, we focus on assessing the effectiveness and limitations of commonly used approaches for transferring pre-clinical knowledge to clinical settings. These include cell-line-validated biomarkers, biologically informed feature representations, direct application of pre-clinical deep-learning models, model fine-tuning, and hybrid strategies that integrate pre-clinical predictions with clinical data. All methods are evaluated within a unified framework using consistent cohort construction, shared performance metrics, and bias-controlled validation procedures. Across multiple drugs and molecular data types, we find that most transfer strategies--including biomarker-based feature selection and direct pre-clinical model transfer--fail to produce robust or consistent improvements in clinical prediction performance. In contrast, conservative approaches based on fine-tuning pre-clinical models or incorporating pre-clinical predictions as features in clinical models yield more stable and reproducible gains. Further improvements are observed when basic pre-treatment clinical variables are integrated. Together, our results demonstrate the practical boundaries of pre-clinical to clinical transfer for drug response prediction and highlight hybrid and fine-tuning strategies as more reliable baselines for future translational modelling efforts.
- organism: human
- assay: bulk RNA-seq
- research focus: benchmarking
- approach: machine learning (classical)
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Predicting clinical drug response from model systems by non-linear subspace-based transfer learning
Soufiane M. C. Mourragui, Marco Loog, … Lodewyk F.A. Wessels·Proceedings of the National Academy of SciencesPeer-reviewed·Dec 3, 2021
- PRECISE: A domain adaptation approach to transfer predictors of drug response from pre-clinical models to tumors
Soufiane M. C. Mourragui, Marco Loog, … Lodewyk F.A. Wessels·BioinformaticsPeer-reviewed·May 9, 2019
- Reusability Report: Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients
Emily So, Fengqing Yu, … Benjamin Haibe‐Kains·bioRxiv·Jul 6, 2023
- Multi-task deep latent spaces for cancer survival and treatment response prediction
Teemu Rintala, Francesco Napolitano, Vittorio Fortino·BioinformaticsPeer-reviewed·Jun 17, 2024
- Training Strategy Optimization to Mitigate Shortcut Learning in Pan-Cancer Drug Response Prediction
Kazuki Shimamoto, Takuma Ito, … Tatsuhiko Tsunoda·bioRxiv·May 27, 2026
- A Survey and Systematic Assessment of Computational Methods for Drug Response Prediction
Jinyu Chen, Louxin Zhang·Briefings in BioinformaticsPeer-reviewed·Nov 23, 2019